NCT00099671View on ClinicalTrials.gov

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2005

Study Completion Date

April 30, 2007

Conditions
HIV Infections
Interventions
DRUG

Recombinant human interleukin-7

Trial Locations (5)

95817

Univ. of California Davis Med. Ctr., ACTU, Sacramento

33136-1013

Univ. of Miami AIDS CRS, Miami

60612-3806

Rush Univ. Med. Ctr. ACTG CRS, Chicago

44106-5083

Case CRS, Cleveland

44109-1998

MetroHealth CRS, Cleveland

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00099671 - Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs | Biotech Hunter | Biotech Hunter